Por: Time Health June 26, 2023
SEATTLE — The next big advance in cancer treatment could be a vaccine. After decades of limited success, scientists say research has reached a turning point, with many predicting more vaccines will be out in five years. These aren’t traditional vaccines that prevent disease, but shots to shrink tumors and stop cancer from coming back. Targets for these experimental treatments include breast and lung cancer, with gains reported this year for... + full article
ABC News USA Business June 28, 2023
SEATTLE -- The next big advance in cancer treatment could be a vaccine.After decades of limited success, scientists say research has reached a turning point, with many predicting more will be out in five years.These aren't traditional vaccines that prevent disease, but... + más
What Are the Duties of A Trustee? | Forbes
NBA playoffs 2023: Our insiders dissect the Eastern and Western conference finals | ABC7
10 WBNS USA Nation June 27, 2023
SEATTLE — The next big advance in cancer treatment could be a vaccine. After decades of limited success, scientists say research has reached a turning point, with many predicting more vaccines will be out in five years. These aren't traditional vaccines that prevent... + más
Woman shares MRI scan to prove how contraceptive pill gave her two tumors | Newsweek
A New Approach to Spotting Tumors: Look for Their Microbes | The New York Times
ABC News USA Health June 26, 2023
The Boston Globe USA Nation December 29, 2022
A new coronavirus variant dubbed XBB has swiftly spreading in the Northeast, jumping from about 35 percent of cases during the week ending Dec. 17 to just over half of cases last week, according to .Here’s a quick primer on what we know about the variant.It is more... + más
Highly Immune Evasive Omicron XBB.1.5 Variant Is Quickly Becoming Dominant in U.S. as It Doubles Weekly | NBC 6 South Florida
Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly | CNBC
ABC7 USA Health October 18, 2022
in an interview over the weekend. Her husband, professor Ugur Sahin, with whom she cofounded the German pharmaceutical company BioNTech, said he thought cancer vaccines could be widely available before 2030.The husband-and-wife duo founded BioNTech in 2008 originally to develop... + más
Cancer vaccine may be ready by 2030, say founders of COVID vaccine makers BioNTech | ABC News
In Boston visit, BioNTech’s leaders say the pandemic isn’t close to being over | The Boston Globe
ABC News USA World October 18, 2022
LONDON -- The world could be only a few years away from a cancer vaccine, according to the couple behind the Pfizer/BioNtech COVID-19 vaccine.We feel that a cure for cancer or to changing cancer patients' lives is in our grasp, professor Ozlem Tureci told in an interview... + más
Cancer vaccine may be ready by 2030, say founders of COVID vaccine-makers BioNTech | ABC7
The New York Times USA Health October 10, 2022
It seems like an almost impossible dream — a cancer vaccine that would protect healthy people at high risk of cancer. Any incipient malignant cells would be obliterated by the immune system. It would be no different from the way vaccines protect against infectious... + más
The Race to Make a Vaccine for Breast Cancer | Time
Mammograms: 3 key questions women should ask before cancer scans | New York Post
About iurex | Privacy Policy | Disclaimer |